Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis.
Chang CV, Conde SJ, Luvizotto RA, Nunes VS, Bonates MC, Felicio AC, Lindsey SC, Moraes FH, Tagliarini JV, Mazeto GM, Kopp P, Nogueira CR.
Chang CV, et al.
Arq Bras Endocrinol Metabol. 2012 Nov;56(8):570-3. doi: 10.1590/s0004-27302012000800018.
Arq Bras Endocrinol Metabol. 2012.
PMID: 23295300